# Gamida Cell Ltd. (GMDA)

Source: https://www.quantisnow.com/company/GMDA
Generated: 2026-11-15T17:01:44.997Z

- Ticker: GMDA
- Exchange: NASDAQ
- Sector: Health Care
- Industry: Biotechnology: Biological Products (No Diagnostic Substances)
- IPO year: 2018
- Website: gamida-cell.com

## About

Gamida Cell Ltd., a clinical-stage biopharmaceutical company, develops cell therapies to cure blood cancers and serious blood diseases. The company's lead product candidate is omidubicel, a cell therapy that is in Phase III studies in patients with high-risk hematologic malignancies, as well as in Phase I/II clinical trials in patients with severe aplastic anemia. It is also developing GDA-201, a natural killer cell-based cancer immunotherapy, which is in Phase I/II studies for the treatment of relapsed or refractory non-Hodgkin lymphoma and multiple myeloma. The company was founded in 1998 and is headquartered in Jerusalem, Israel.

## Latest GMDA news and filings

- 2025-05-12 11:30 UTC [Public Offering] [Purple Biotech Appoints Shai Lankry as Chief Financial Officer](https://www.quantisnow.com/insight/purple-biotech-appoints-shai-lankry-as-chief-financial-officer-6031678)
- 2024-07-22 12:30 UTC [Leadership Update] [HOOKIPA Pharma Announces Leadership Changes to Intensify Focus on HB-200](https://www.quantisnow.com/insight/hookipa-pharma-announces-leadership-changes-to-intensify-focus-on-hb-200-5619061)
- 2024-05-14 04:15 UTC [SEC Form EFFECT] [SEC Form EFFECT filed by Gamida Cell Ltd.](https://www.quantisnow.com/insight/sec-form-effect-filed-by-gamida-cell-ltd-5486933)
- 2024-05-14 04:15 UTC [SEC Form EFFECT] [SEC Form EFFECT filed by Gamida Cell Ltd.](https://www.quantisnow.com/insight/sec-form-effect-filed-by-gamida-cell-ltd-5486920)
- 2024-05-14 04:15 UTC [SEC Form EFFECT] [SEC Form EFFECT filed by Gamida Cell Ltd.](https://www.quantisnow.com/insight/sec-form-effect-filed-by-gamida-cell-ltd-5486912)
- 2024-05-10 20:19 UTC [SEC Form 8-K] [Gamida Cell Ltd. filed SEC Form 8-K: Other Events, Financial Statements and Exhibits (Amendment)](https://www.quantisnow.com/insight/gamida-cell-ltd-filed-sec-form-8-k-other-events-financial-5482049)
- 2024-05-09 20:08 UTC [SEC Form S-8 POS] [SEC Form S-8 POS filed by Gamida Cell Ltd.](https://www.quantisnow.com/insight/sec-form-s-8-pos-filed-by-gamida-cell-ltd-5477588)
- 2024-05-09 20:06 UTC [SEC Form S-8 POS] [SEC Form S-8 POS filed by Gamida Cell Ltd.](https://www.quantisnow.com/insight/sec-form-s-8-pos-filed-by-gamida-cell-ltd-5477457)
- 2024-05-09 20:05 UTC [SEC Form S-8 POS] [SEC Form S-8 POS filed by Gamida Cell Ltd.](https://www.quantisnow.com/insight/sec-form-s-8-pos-filed-by-gamida-cell-ltd-5477437)
- 2024-05-09 20:04 UTC [SEC Form POS AM filed by Gamida Cell Ltd.](https://www.quantisnow.com/insight/sec-form-pos-am-filed-by-gamida-cell-ltd-5477404)
- 2024-05-09 20:02 UTC [SEC Form POS AM filed by Gamida Cell Ltd.](https://www.quantisnow.com/insight/sec-form-pos-am-filed-by-gamida-cell-ltd-5477234)
- 2024-05-09 20:01 UTC [SEC Form POS AM filed by Gamida Cell Ltd.](https://www.quantisnow.com/insight/sec-form-pos-am-filed-by-gamida-cell-ltd-5477172)
- 2024-04-25 13:10 UTC [SEC Form 25-NSE filed by Gamida Cell Ltd.](https://www.quantisnow.com/insight/sec-form-25-nse-filed-by-gamida-cell-ltd-5432354)
- 2024-04-22 21:26 UTC [SEC Form 8-K] [Gamida Cell Ltd. filed SEC Form 8-K: Bankruptcy or Receivership](https://www.quantisnow.com/insight/gamida-cell-ltd-filed-sec-form-8-k-bankruptcy-or-receivership-5424357)
- 2024-04-11 21:26 UTC [SEC Form 8-K] [Gamida Cell Ltd. filed SEC Form 8-K: Other Events, Financial Statements and Exhibits (Amendment)](https://www.quantisnow.com/insight/gamida-cell-ltd-filed-sec-form-8-k-other-events-financial-5406591)
- 2024-04-08 11:30 UTC [Leadership Update] [XORTX Welcomes New Member to the Board of Directors](https://www.quantisnow.com/insight/xortx-welcomes-new-member-to-the-board-of-directors-5396565)
- 2024-04-05 21:16 UTC [SEC Form 8-K] [Gamida Cell Ltd. filed SEC Form 8-K: Other Events, Financial Statements and Exhibits (Amendment)](https://www.quantisnow.com/insight/gamida-cell-ltd-filed-sec-form-8-k-other-events-financial-5395903)
- 2024-04-03 17:56 UTC [Market Insight] [Why Ulta Beauty Shares Are Trading Lower By Around 14%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session](https://www.quantisnow.com/insight/why-ulta-beauty-shares-are-trading-lower-by-around-14-5388304)
- 2024-04-03 12:10 UTC [Market Insight] [Why Cal-Maine Foods Shares Are Trading Higher By Around 8%; Here Are 20 Stocks Moving Premarket](https://www.quantisnow.com/insight/why-cal-maine-foods-shares-are-trading-higher-by-around-8-5387302)
- 2024-04-01 21:49 UTC [SEC Schedule 13G] [SEC Form SC 13G/A filed by Gamida Cell Ltd. (Amendment)](https://www.quantisnow.com/insight/sec-form-sc-13ga-filed-by-gamida-cell-ltd-amendment-5382077)
- 2024-04-01 12:00 UTC [Leadership Update] [Aquestive Therapeutics Strengthens Board of Directors with Experienced Biotech Executive](https://www.quantisnow.com/insight/aquestive-therapeutics-strengthens-board-of-directors-with-experienced-biotech-executive-5378992)
- 2024-03-29 01:47 UTC [SEC Form 8-K] [Gamida Cell Ltd. filed SEC Form 8-K: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing (Amendment)](https://www.quantisnow.com/insight/gamida-cell-ltd-filed-sec-form-8-k-notice-of-delisting-5377016)
- 2024-03-28 18:08 UTC [Market Insight] [Why Kodiak Sciences Shares Are Trading Lower By Around 20%? Here Are Other Stocks Moving In Thursday's Mid-Day Session](https://www.quantisnow.com/insight/why-kodiak-sciences-shares-are-trading-lower-by-around-20-5375222)
- 2024-03-28 14:32 UTC [Market Insight] [US Stocks Flat; Initial Jobless Claims Fall To 210,000](https://www.quantisnow.com/insight/us-stocks-flat-initial-jobless-claims-fall-to-210000-5374701)
- 2024-03-28 12:21 UTC [Market Insight] [Why RH Shares Are Trading Higher By Around 9%; Here Are 20 Stocks Moving Premarket](https://www.quantisnow.com/insight/why-rh-shares-are-trading-higher-by-around-9-here-5374201)
- 2024-03-27 19:24 UTC [Market Insight] [Gold Moves Higher; Velo3D Shares Plummet](https://www.quantisnow.com/insight/gold-moves-higher-velo3d-shares-plummet-5372128)
- 2024-03-27 17:06 UTC [Market Insight] [Why LuxUrban Hotels Shares Are Trading Lower By Around 27%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session](https://www.quantisnow.com/insight/why-luxurban-hotels-shares-are-trading-lower-by-around-27-5371887)
- 2024-03-27 16:00 UTC [Market Insight] [Crude Oil Edges Lower; PaySign Shares Spike Higher](https://www.quantisnow.com/insight/crude-oil-edges-lower-paysign-shares-spike-higher-5371751)
- 2024-03-27 13:42 UTC [Market Insight] [Why Gamida Cell Shares Are Falling Today](https://www.quantisnow.com/insight/why-gamida-cell-shares-are-falling-today-5371419)
- 2024-03-27 13:39 UTC [Market Insight] [Dow Jumps Over 200 Points; UniFirst Posts Downbeat Earnings](https://www.quantisnow.com/insight/dow-jumps-over-200-points-unifirst-posts-downbeat-earnings-5371415)
- 2024-03-27 11:35 UTC [SEC Form 10-K] [SEC Form 10-K filed by Gamida Cell Ltd.](https://www.quantisnow.com/insight/sec-form-10-k-filed-by-gamida-cell-ltd-5370868)
- 2024-03-27 11:30 UTC [SEC Form 8-K] [Gamida Cell Ltd. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Results of Operations and Financial Condition, Events That Accelerate or Increase a Direct Financial Obligation, Costs Associated with Exit or Disposal Activities, Leadership Update, Other Events, Financial Statements and Exhibits](https://www.quantisnow.com/insight/gamida-cell-ltd-filed-sec-form-8-k-entry-into-a-5370846)
- 2024-03-27 11:17 UTC [Market Chatter] [Gamida Cell shares are trading lower after the company reported Q4 results and disclosed the commencement of a restructuring process.](https://www.quantisnow.com/insight/gamida-cell-shares-are-trading-lower-after-the-company-reported-5370791)
- 2024-03-27 11:09 UTC [Market Chatter] [Gamida Cell Discloses Commencement Of Restructuring Process Supported By Highbridge Capital Management](https://www.quantisnow.com/insight/gamida-cell-discloses-commencement-of-restructuring-process-supported-by-highbridge-5370767)
- 2024-03-27 11:07 UTC [Market Chatter] [Gamida Cell Reports Net Loss Per Share Of $(0.57) For FY23, Holds Cash And Equivalents Worth $46.6M As Of December 31, 2023](https://www.quantisnow.com/insight/gamida-cell-reports-net-loss-per-share-of-057-for-5370764)
- 2024-03-27 11:00 UTC [Gamida Cell Announces Commencement of Restructuring Process Supported by Highbridge Capital Management](https://www.quantisnow.com/insight/gamida-cell-announces-commencement-of-restructuring-process-supported-by-highbridge-5370712)
- 2024-03-27 11:00 UTC [Public Offering] [Gamida Cell Reports Fourth Quarter and Full-Year 2023 Financial Results and Provides Company Update](https://www.quantisnow.com/insight/gamida-cell-reports-fourth-quarter-and-full-year-2023-financial-results-5370710)
- 2024-03-27 09:02 UTC [Market Insight] [Earnings Scheduled For March 27, 2024](https://www.quantisnow.com/insight/earnings-scheduled-for-march-27-2024-5370475)
- 2024-03-26 17:00 UTC [Market Insight] [Gamida Cell Earnings Preview](https://www.quantisnow.com/insight/gamida-cell-earnings-preview-5368959)
- 2024-03-22 12:00 UTC [Earnings Date] [Gamida Cell to Report Fourth Quarter and Full-Year 2023 Financial Results](https://www.quantisnow.com/insight/gamida-cell-to-report-fourth-quarter-and-full-year-2023-financial-5362595)

## More

- Live page with ratings, short volume, options and peers: https://www.quantisnow.com/company/GMDA
- Earnings history: https://www.quantisnow.com/earnings/GMDA
- Dividend history: https://www.quantisnow.com/dividends/GMDA
- Insider transactions: https://www.quantisnow.com/insiders/GMDA
- Options chain: https://www.quantisnow.com/options/GMDA
- SEC 8-K filings only: https://www.quantisnow.com/company/GMDA/8-k
- RSS and alerts for GMDA: https://www.quantisnow.com/docs/rss-feeds.md